EC
ABBV icon

EdgeRock Capital’s AbbVie ABBV Stock Holding History

EdgeRock Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$527K Buy
2,423
+98
+4% +$21.7K 0.14% 67
2025
Q4 		$531K Buy
2,325
+96
+4% +$21.9K 0.14% 69
2025
Q3 		$516K Buy
2,229
+75
+3% +$15.3K 0.14% 68
2025
Q2 		$399K Buy
2,154
+136
+7% +$25.3K 0.13% 69
2025
Q1 		$423K Buy
2,018
+113
+6% +$22K 0.3% 44
2024
Q4 		$339K Buy
1,905
+101
+6% +$18.6K 0.22% 52
2024
Q3 		$356K Buy
1,804
+88
+5% +$16.4K 0.25% 49
2024
Q2 		$294K Buy
1,716
+304
+22% +$50.4K 0.23% 43
2024
Q1 		$257K Buy
1,412
+47
+3% +$8.1K 0.2% 50
2023
Q4 		$232K Buy
+1,365
New +$199K 0.17% 53
2022
Q4 		– Sell
-866
Closed -$116K – 61
2022
Q3 		$116K Buy
+866
New +$124K 0.07% 73

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return